Chen Shih-Yen, Feng Ye, Chao Hsun-Chin, Lai Ming-Wei, Huang Wen-Ling, Lin Chun-Yuan, Tsai Chi-Neu, Chen Chyi-Liang, Chiu Cheng-Hsun
Division of Pediatric Gastroenterology, Chang Gung Children's Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan, ROC.
Institute for Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, PR China.
J Med Microbiol. 2015 May;64(Pt 5):544-550. doi: 10.1099/jmm.0.000046. Epub 2015 Mar 9.
Norovirus is the leading cause of viral gastroenteritis globally. Norovirus genotype GII.4 is responsible for the majority of outbreaks, but new variants are continuously emerging. The objective of the study was to delineate the clinical manifestations and complications associated with these new norovirus GII.4 variants in children. We investigated norovirus infections from the community outbreak in October 2011-September 2012 and an earlier outbreak in 2006-2007, in northern Taiwan. Norovirus genotypes and their variants were validated using molecular methods. A norovirus outbreak started in mid-2011 and continued through 2012 in northern Taiwan. Hospitalized children infected by norovirus in 2012 showed a significantly higher incidence of intestinal haemorrhage, as indicated by grossly bloody faeces (P=0.012) and occult blood in faeces (P < 0.001), and also presented with more high fever >39 °C (P < 0.001), fever >38.5 °C (P < 0.001) and fever of any temperature >38 °C (P < 0.001), compared with children hospitalized in 2006-2007. Analysis of 20 near-full-length genome sequences indicated an emergence of GII.4 2012 variants in 2011-2012. Circulating noroviruses can be divided into two clusters: GII.4 2012a, which is identical to the newly reported strain GII.4 Sydney 2012, and GII.4 2012b, which is close to GII.4 2006b, the earlier predominant strain. The emerging new variants of norovirus GII.4 caused a distinct clinical syndrome of acute gastroenteritis with severe fever and a high rate of intestinal haemorrhage in children. The genetic diversity associated with changing clinical manifestations poses major obstacles to norovirus control.
诺如病毒是全球病毒性肠胃炎的主要病因。诺如病毒GII.4基因型是大多数疫情爆发的罪魁祸首,但新变种不断涌现。本研究的目的是描述与儿童中这些新的诺如病毒GII.4变种相关的临床表现和并发症。我们调查了2011年10月至2012年9月台湾北部社区疫情以及2006年至2007年的一次早期疫情中的诺如病毒感染情况。使用分子方法对诺如病毒基因型及其变种进行了验证。2011年年中在台湾北部爆发了诺如病毒疫情,并持续到2012年。2012年感染诺如病毒的住院儿童出现肠道出血的发生率显著更高,表现为肉眼可见的血性粪便(P = 0.012)和粪便潜血(P < 0.001),与2006年至2007年住院的儿童相比,还出现更多体温>39°C(P < 0.001)、体温>38.5°C(P < 0.001)以及任何体温>38°C(P < 0.001)的高烧情况。对20个近全长基因组序列的分析表明,2011 - 2012年出现了GII.4 2012变种。流行的诺如病毒可分为两个簇:GII.4 2012a,与新报告的毒株GII.4悉尼2012相同;GII.4 2012b,与早期的优势毒株GII.4 2006b相近。新出现的诺如病毒GII.4变种导致了一种独特的急性肠胃炎临床综合征,伴有严重发热和儿童肠道出血的高发生率。与临床表现变化相关的遗传多样性给诺如病毒的控制带来了重大障碍。